Movement Alert|WuXi XDC Declines 3.14% in Regular Trading, Trading at 56.7 HKD

Market Focus05-26

On May 26, WuXi XDC (02268.HK) fell 3.14% in regular trading, trading at 56.7 HKD/share, with trading volume of 70.50 million HKD.

Within the Life Sciences Tools & Services sector where WuXi XDC belongs, individual stock performance was mixed. Among sector peers, WuXi Biologics up 5.01%, GenScript Biotech up 0.31%, WuXi AppTec down 1.31%, XtalPi down 2.01%, Insilico Medicine down 3.13%.

WuXi XDC is a leading investment holding company primarily engaged in providing comprehensive contract research, development, and manufacturing organization (CRDMO) services for antibody-drug conjugates (ADCs) and other bioconjugate drugs, with operations spanning the domestic market, North America, Europe, and other regions worldwide.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment